Zealand Pharma A/S
CPSE:ZEAL
kr 295,00
+ kr1,00 (0,34%)
295,00 kr
+kr1,00 (0,34%)
End-of-day quote: 03/31/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

G
71,10%
5-year Growth Rate
R
4/6
5-year Risk Analysis
O
-51,93%
Outlook 12/26
W
89,82%
Margin of safety
T
69,49%
Analyst Price Target
H
DOWN
50-week EMA Trend

Company Info

EPS Growth 5Y
42,12%
Revenue growth 5Y
71,10%
Price growth 5Y
47,06%
Market Cap
kr20,83 B
Long-Term Debt
kr0,30 B
Quarterly earnings
05/08/2026 (E)
Dividend
kr0,00
Dividend Yield
0,00%
Industry
Country
ISIN Number

Zealand Pharma A/S Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

kr500,00
69.49%
69.49
Last Update: 04/01/2026
Analysts: 15

Highest Price Target kr825,00

Average Price Target kr500,00

Lowest Price Target kr275,00

Top growth stocks in the health care sector

Stock Rate of Return 5Y Price 5Y Div. 5Y G R O W T H
Zealand Pharma A/S
CPSE:ZEAL
47,06% 47,06% 0,00% 71,10% 4/6 -51,93% 89,82% 69,49% DOWN
×